Human mesenchymal stem/stromal cell based-therapy in diabetes mellitus: experimental and clinical perspectives.
Ontology highlight
ABSTRACT: Diabetes mellitus (DM), a chronic metabolic disease, poses a significant global health challenge, with current treatments often fail to prevent the long-term disease complications. Mesenchymal stem/stromal cells (MSCs) are, adult progenitors, able to repair injured tissues, exhibiting regenerative effects and immunoregulatory and anti-inflammatory responses, so they have been emerged as a promising therapeutic approach in many immune-related and inflammatory diseases. This review summarizes the therapeutic mechanisms and outcomes of MSCs, derived from different human tissue sources (hMSCs), in the context of DM type 1 and type 2. Animal model studies and clinical trials indicate that hMSCs can facilitate pleiotropic actions in the diabetic milieu for improved metabolic indices. In addition
SUBMITTER: Zeinhom A
PROVIDER: S-EPMC11520428 | biostudies-literature | 2024 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA